Heini J. Lassus

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

p53 Normal and p53 Abnormal Clear Cell Ovarian Carcinomas: Clinical Characteristics and Biomarker Profiles.

p53 Normal and p53 Abnormal Clear Cell Ovarian Carcinomas: Clinical Characteristics and Biomarker Profiles.

Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists

Published: November 24, 2025

Ex Vivo Immuno-Oncology Platform Reveals Spatial T-cell Infiltration Patterns Linked to ATR Inhibition Responses in High-Grade Serous Ovarian Cancer.

Ex Vivo Immuno-Oncology Platform Reveals Spatial T-cell Infiltration Patterns Linked to ATR Inhibition Responses in High-Grade Serous Ovarian Cancer.

Journal: Cancer immunology research

Published: June 18, 2025

Oncolytic adenoviruses in platinum-resistant ovarian cancer: a new era in immunotherapy?

Oncolytic adenoviruses in platinum-resistant ovarian cancer: a new era in immunotherapy?

Journal: Expert opinion on biological therapy

Published: May 05, 2025

Comparative analysis of European guideline-based clinicopathological risk groups and the International Federation of Gynecology and Obstetrics staging system for endometrial cancer.

Comparative analysis of European guideline-based clinicopathological risk groups and the International Federation of Gynecology and Obstetrics staging system for endometrial cancer.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: January 04, 2025

PErsonalized TReatment for Endometrial Carcinoma (PETREC): study design and methods of a prospective Finnish multicenter trial.

PErsonalized TReatment for Endometrial Carcinoma (PETREC): study design and methods of a prospective Finnish multicenter trial.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: October 09, 2023

Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes.

Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 18, 2022

Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma.

Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma.

Journal: British journal of cancer

Published: April 13, 2022

Real-life data on treatment and outcomes in advanced ovarian cancer: An observational, multinational cohort study (RESPONSE trial).

Real-life data on treatment and outcomes in advanced ovarian cancer: An observational, multinational cohort study (RESPONSE trial).

Journal: Cancer

Published: January 20, 2022

TCGA molecular classification in endometriosis-associated ovarian carcinomas: Novel data on clear cell carcinoma.

TCGA molecular classification in endometriosis-associated ovarian carcinomas: Novel data on clear cell carcinoma.

Journal: Gynecologic oncology

Published: January 17, 2022

Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246-Sensitive Disease Subtype.

Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246-Sensitive Disease Subtype.

Journal: Molecular cancer therapeutics

Published: July 19, 2021

Clinical factors and biomarker profiles associated with patient outcome in endometrioid ovarian carcinoma - Emphasis on tumor grade.

Clinical factors and biomarker profiles associated with patient outcome in endometrioid ovarian carcinoma - Emphasis on tumor grade.

Journal: Gynecologic oncology

Published: June 15, 2021

Incidence of extraovarian clear cell cancers in women with surgically diagnosed endometriosis: A cohort study.

Incidence of extraovarian clear cell cancers in women with surgically diagnosed endometriosis: A cohort study.

Journal: PloS one

Published: February 02, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026